FDA approves generic version of Jazz Pharmas sleep disorder drug The U.

Meals and Medication Administration head office in Silver Springtime, August 14 maryland, 2012. REUTERS/Jason Reed/Document Photo The accepted generic is produced by Roxane Laboratories Inc, the FDA informed Reuters.6 % at $108.tuesday 00 in after-hours trading on. Xyrem may be the only approved treatment for both excessive day time sleepiness and cataplexy in individuals with narcolepsy, a chronic neurological disorder. Cataplexy, among the primary as well as the most debilitating symptoms of narcolepsy, causes an abrupt loss of muscle mass control, resulting in physical collapse.Trivedi arranged EMBARC with other educational centers following the world’s largest depressive disorder research that he led greater than a 10 years ago comprehensive shortcomings in individual care. Among various other major results, the Celebrity*D studies discovered that as much as two-thirds of sufferers do not effectively react to their initial antidepressant. Dr. Trivedi sought to boost this example by spearheading the 16-week EMBARC trial at four U.S.